Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Checkpoint Therapeutics Raises USD57.8 Million Venture Financing 11
Partnerships 12
Applied BioMath Enters into Agreement with Checkpoint Therapeutics 12
Checkpoint Therapeutics Enters into Research Agreement with NeuPharma 13
TG Therapeutics Extends its Option Agreement with Checkpoint Therapeutics 14
TG Therapeutics Enters into Agreement with Checkpoint Therapeutics to Develop and Commercialize Immuno-Oncology Targeted Antibodies 15
Licensing Agreements 16
Checkpoint Therapeutics Amends its Licensing Agreement with Jubilant Biosys 16
Checkpoint Therapeutics Enters into Licensing Agreement with Cephalon 17
Checkpoint Therapeutics Amends its Licensing Agreement with Dana-Farber Cancer Institute 18
Equity Offering 20
Checkpoint Therapeutics Prices Public Offering of Shares for USD20 Million 20
Checkpoint Therapeutics Plans to Raise up to USD100 Million in Public Offering of Shares 22
Checkpoint Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 23
Checkpoint Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Checkpoint Therapeutics Raises USD58 Million in Private Placement of Units 25
Checkpoint Therapeutics Inc – Key Competitors 26
Checkpoint Therapeutics Inc – Key Employees 27
Checkpoint Therapeutics Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Nov 02, 2018: Checkpoint Therapeutics reports third quarter 2018 financial results and recent corporate highlights 29
Aug 07, 2018: Checkpoint Therapeutics announces second quarter 2018 financial results 30
May 10, 2018: Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights 31
Mar 15, 2018: Checkpoint Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results 32
Corporate Communications 33
Oct 16, 2018: Checkpoint Therapeutics names Christian Bechon to its Board of Directors 33
Clinical Trials 34
Apr 18, 2018: Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting 34
Mar 15, 2018: TG Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting 35
Mar 15, 2018: TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting 36
Mar 20, 2017: Checkpoint Therapeutics to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2017 37
Other Significant Developments 38
Jan 11, 2018: Adimab Initiates Update on Clinical Progression of Partner Programs 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Checkpoint Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Checkpoint Therapeutics Raises USD57.8 Million Venture Financing 11
Applied BioMath Enters into Agreement with Checkpoint Therapeutics 12
Checkpoint Therapeutics Enters into Research Agreement with NeuPharma 13
TG Therapeutics Extends its Option Agreement with Checkpoint Therapeutics 14
TG Therapeutics Enters into Agreement with Checkpoint Therapeutics to Develop and Commercialize Immuno-Oncology Targeted Antibodies 15
Checkpoint Therapeutics Amends its Licensing Agreement with Jubilant Biosys 16
Checkpoint Therapeutics Enters into Licensing Agreement with Cephalon 17
Checkpoint Therapeutics Amends its Licensing Agreement with Dana-Farber Cancer Institute 18
Checkpoint Therapeutics Prices Public Offering of Shares for USD20 Million 20
Checkpoint Therapeutics Plans to Raise up to USD100 Million in Public Offering of Shares 22
Checkpoint Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 23
Checkpoint Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Checkpoint Therapeutics Raises USD58 Million in Private Placement of Units 25
Checkpoint Therapeutics Inc, Key Competitors 26
Checkpoint Therapeutics Inc, Key Employees 27
List of Figures
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Checkpoint Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer